Mayo Clinic has joined a $13 million funding round for BrightInsight, a digital health startup focused on medical adherence.
The Rochester, Minn.-based health system is among the new investors in the company, along with such venture capital firms as General Catalyst.
BrightInsight offers AI-powered digital solutions to boost medication compliance, including an app in partnership with pharma companies Sanofi and Regeneron. The startup plans to use the new funding to advance use cases like predicting medication “churn” and expand to more disease-specific partners, according to a Jan. 20 news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
